Dr. Alec Sandy Koo, MD

Dr. Koo practices at Genesis Healthcare Partners in Torrance, California.

Dr. Koo's NPI, 1740236066, was assigned on May 26, 2006. Dr. Koo graduated from David Geffen School of Medicine at UCLA in 1986. Dr. Koo holds California license G61375.

Dr. Koo's primary practice is Genesis Healthcare Partners, at 23600 Telo Ave, Torrance, CA 90505 in Los Angeles County. The practice phone is (760) 436-4558.

Dr. Koo's primary practice is Genesis Healthcare Partners in Torrance, California. Dr. Koo is also affiliated with Torrance Memorial Medical Center. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. Koo to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koo practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Koo's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Koo is board certified in urology by the American Board of Urology. Dr. Koo is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Dr. Koo treats.

CMS data shows 7,868 Medicare services from Dr. Koo across 25 procedure codes in 2024, for 621 Medicare patients. Medicare paid $437,968 for them. Every service was in an office.

CMS counts 621 Medicare patients who saw Dr. Koo in 2024. The largest group is 65 to 74, with 240 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Koo's median patient age at 70, with 20% women.

In 2024, Dr. Koo wrote 2,009 Medicare Part D claims for 486 patients. 93% of them were for generic drugs. CMS names the drug for 1,868 of them, across 26 drugs with 11 or more claims each, at $370,089 in total drug cost. In 2023, CMS named 1,745 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Koo for performance year 2024, reported as part of a group. Dr. Koo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koo as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Koo, published from 2017 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms. Dr. Koo has published most often in Urology. Dr. Koo's most frequent co-authors are Timothy J. Bradford, MD, Edward Steven Cohen, MD and Franklin D. Gaylis, MD.

CMS Open Payments shows 940 general payments to Dr. Koo from 67 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Abbvie Inc. paid the most, $137,401.

Dmand AI lists 2 awards for Dr. Koo.

Dr. Koo graduated from David Geffen School of Medicine at UCLA in 1986. Dr. Koo is a member of ACS.

Dr. Koo is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.